Biotech Values

[tekcor_atnm]

...if Teva has the real goods, and they acquired the real goods without trampling over MNTA IP, then why would Teva be so concerned about such protocols in relation to the litigation?

that is, unless, Teva either does not expect approval, or Teva has indeed trampled MNTA IP.

Could a third possibility be that TEVA does not know for sure if they are infringing -or- have some inkling that the patents are unenforceable against their methods? Then we are back to TEVA proceeding as they have been and letting a judge decide.